Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada

Moderna's mRNA flu and flu-COVID combo vaccines have now received approval from Health Canada, marking a significant step forward in vaccine technology. This authorization could help streamline the administration process by offering a single shot to protect against both influenza and COVID-19, potentially reducing the burden on healthcare systems. The approval underscores the growing importance of mRNA technology in developing effective and efficient vaccines, highlighting its potential to address multiple health threats simultaneously. This move is likely to influence global vaccination strategies as it offers a more comprehensive approach to seasonal and pandemic influenza.